Notably, the present clinical data demonstrated that the percentage of Naïve CD4+ T cells and TCM were all significantly increased, but CD4+ TEM and CD8+ TEM declined in these T1D subjects after receiving SCE therapy. This evidence concerns the gene CD8A and type 1 diabetes mellitus.